Women's Health News

RSS

Study finds disparities in breast cancer screening, treatment access for underserved communities

Barriers to breast cancer screening remain despite Medicaid expansion for preventive screening tests and implementation of patient navigation programs under the Affordable Care Act, with women from underserved communities experiencing disproportionately low rates of screening mammography, according to a study that was conducted by New York Medical College (NYMC) School of Medicine (SOM) faculty and students and recently published in BMC Women’s Health.

9 Dec 2022

Microbiomes in female reproductive tract linked to pregnancy following use of ART

Specific microbial profiles are associated with better conception rates from assisted reproductive technology.

9 Dec 2022

Vaping during pregnancy may give babies a greater propensity to develop pulmonary disease

Babies born to mothers who vape during pregnancy are at greater risk of developing pulmonary dysfunction, according to a new mouse study from The Ohio State University.

8 Dec 2022

Study reveals how the HOXA5 gene may work to suppress breast cancer formation

Researchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to suppress formation of breast cancers.

8 Dec 2022

Estrogen replacement therapy may be a tool to mitigate delirium

Delirium is common among women with urinary tract infections (UTIs) - especially those who have experienced menopause.

8 Dec 2022

Trial establishes the clinical utility of circulating tumor cell count as biomarker in breast cancer care

The use of circulating tumor cell (CTC) count to guide the choice between chemotherapy and endocrine therapy as first-line therapy for patients with metastatic, estrogen receptor (ER)-positive/HER2-negative breast cancer provided overall survival benefit, compared with physician's choice of treatment, according to data from the STIC CTC trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

8 Dec 2022

VirtaMed and CICE to announce partnership for gynecological endoscopy certification

...

From VirtaMed 8 Dec 2022

More states to consider extending postpartum Medicaid coverage beyond two months

Updated results on a new approach to treating advanced ER-positive/HER2-negative breast cancer

A UCLA Jonsson Comprehensive Cancer Center researcher and collaborators in a multicenter study will present updated results and plans for further research on a new approach to treating advanced ER-positive/HER2-negative breast cancer.

7 Dec 2022

T-DXd leads to longer overall survival in HER2-positive metastatic breast cancer patients than T-DM1

Second-line treatment with trastuzumab deruxtecan (T-DXd) led to significantly longer overall survival compared with trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer, according to updated results from the DESTINY-Breast03 phase III clinical trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

T-DXd shows high efficacy in HER2-positive breast cancer patients previously treated with T-DM1

Compared with capecitabine-based regimens, trastuzumab deruxtecan (T-DXd) led to higher response rates and longer survival in the third-line setting for patients with HER2-positive metastatic breast cancer previously treated with trastuzumab emtansine (T-DM1), according to results from the phase III DESTINY-Breast02 trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

HIV transmission from mother to child can be stopped with modern antiviral drugs

Antiviral drugs almost completely reduce the risk of mothers passing on HIV infection to their children, even in a low-income country with a high HIV incidence such as Tanzania, according to a new study in The Lancet HIV by researchers from Karolinska Institutet.

7 Dec 2022

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

Patients with localized, hormone receptor-positive, HER2-low breast cancer treated with trastuzumab deruxtecan (T-DXd, Enhertu) in the neoadjuvant setting had an overall response rate of 75 percent in the absence of anastrozole and 63 percent in combination with anastrozole, according to results from the phase II TRIO-US B-12 TALENT trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

New ASTRO guideline provides recommendations on the use of radiation therapy for endometrial cancer

A newly updated clinical guideline from the American Society for Radiation Oncology provides recommendations on the use of radiation therapy and systemic therapy after surgery to treat patients with endometrial cancer.

7 Dec 2022

Genomic assay can help identify breast cancer patients who may benefit from ovarian suppression therapy

Among premenopausal women with hormone receptor (HR)-positive, early-stage breast cancer enrolled in the SOFT trial, those with a high score on a genomic assay called Breast Cancer Index (BCI) had increased risk of distant recurrence, and those with low BCI benefited more from the addition of ovarian suppression therapy to endocrine therapy after 12 years of follow-up, according to data presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

Drug overdose deaths reach a record high among pregnant and postpartum women, study reveals

Drug overdose deaths among pregnant and postpartum women increased more than 180 percent in the past five years, according to a new study conducted at Columbia University Mailman School of Public Health.

6 Dec 2022

Gestational diabetes mellitus linked to early particulate matter exposure with high BMI

Researchers assess the impact of high BMI before pregnancy, coupled with exposure to different levels of PM, on the incidence of gestational diabetes.

6 Dec 2022

Ochsner Medical Center earns "high performing" rating by U.S. News & World Report for maternity care

Ochsner Medical Center – New Orleans, inclusive of Ochsner Medical Center- West Bank Campus and Ochsner Baptist, is the highest-rated maternity hospital in Louisiana, according to Best Hospital for Maternity ratings released today by U.S. News & World Report – the global authority on hospital ratings and consumer advice.

6 Dec 2022

COVID-19 vaccination may cause temporary menstrual disturbances in adolescent girls

The Pfizer-BioNTech mRNA-based COVID-19 vaccine may increase the risk of menstrual disturbances in adolescent girls in their first cycle after vaccination.

6 Dec 2022

Eating ultra-processed foods increases risk of cognitive decline

The consumption of ultra-processed foods increases the risk of cognitive decline, particularly among middle-aged adults.

5 Dec 2022

Women's Health News

Study finds disparities in breast cancer screening, treatment access for underserved communities

Microbiomes in female reproductive tract linked to pregnancy following use of ART

Vaping during pregnancy may give babies a greater propensity to develop pulmonary disease

Study reveals how the HOXA5 gene may work to suppress breast cancer formation

Estrogen replacement therapy may be a tool to mitigate delirium

Trial establishes the clinical utility of circulating tumor cell count as biomarker in breast cancer care

VirtaMed and CICE to announce partnership for gynecological endoscopy certification

More states to consider extending postpartum Medicaid coverage beyond two months

Updated results on a new approach to treating advanced ER-positive/HER2-negative breast cancer

T-DXd leads to longer overall survival in HER2-positive metastatic breast cancer patients than T-DM1

T-DXd shows high efficacy in HER2-positive breast cancer patients previously treated with T-DM1

HIV transmission from mother to child can be stopped with modern antiviral drugs

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

New ASTRO guideline provides recommendations on the use of radiation therapy for endometrial cancer

Genomic assay can help identify breast cancer patients who may benefit from ovarian suppression therapy

Drug overdose deaths reach a record high among pregnant and postpartum women, study reveals

Gestational diabetes mellitus linked to early particulate matter exposure with high BMI

Ochsner Medical Center earns "high performing" rating by U.S. News & World Report for maternity care

COVID-19 vaccination may cause temporary menstrual disturbances in adolescent girls

Eating ultra-processed foods increases risk of cognitive decline

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News